The Business Times

BioNTech

Opinion & Features
THE BOTTOM LINE

Why China biotech is getting a DeepSeek moment, too

The vaccine (not pictured) failed to show it was at least as effective as a standard shot in generating an immune response against the influenza B strain, the two companies say.
Consumer & Healthcare

Pfizer-BioNTech Covid-flu combo vaccine misses on trial goal

BioNTech reported a second-quarter net loss of 807.8 million euros (S$1.2 billion), versus a loss of 190.4 million a year earlier.
Consumer & Healthcare

BioNTech counts on shift to cancer drugs after second quarter losses quadruple

FILE PHOTO: A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay/File Photo
Companies & Markets

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

BioNTech says it maps out plans to launch its first oncology drugs from 2026 onwards.
Consumer & Healthcare

BioNTech predicts return to revenue growth in 2025

Pfizer and BioNTech agreed to supply the European Union with 900 million Covid-19 vaccine doses by the end of 2023, though that amount might change due to a supply glut.
International

EU may pay more for Pfizer Covid vaccines in return for lower volume

Under the German vaccine maker’s largest takeover deal to date, BioNTech is to pay £362 million upfront, in a mix of cash and an unspecified number of BioNTech shares, and up to £200 million contingent on InstaDeep’s future performance.
Companies & Markets

Germany's BioNTech buys British AI startup InstaDeep

The booster shots offered are recommended for those aged 18 and above and those who have completed their initial course of vaccination, according to Fosun Pharmaceutical.
Companies & Markets

Fosun app lets China users get BioNTech Covid vaccines in Hong Kong

An employee holds up a vial of an oncological product under development, at the BioNTeCH research institute in Mainz, Rhineland-Palatinate, western Germany, on October 5, 2022. (Photo by ANDRE PAIN / AFP)
Companies & Markets

Vaccine pioneer sees mRNA technology’s limits in treating cancer

A ministry spokeswoman says China and Germany have reached agreement on providing German vaccines for German nationals in China.
International

Beijing approves mRNA vaccines for German nationals in China

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More